Difference in the effect of orthokeratology on slowing teen myopia with different years of follow-up

Meng, Zhihua; Shuo, G; Guohu, D; Wei, Zhihao; Jingyi, L; Yuanchao, C; Zhaodong, L; Yu, Chunlei

doi:10.1016/j.jfo.2022.02.003

Cited by 2 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Atropine, a muscarinic antagonist, has been shown to inhibit myopia progression by slowing axial elongation of the eyeball. [11][12][13] On the other hand, OK lenses are rigid contact lenses designed to temporarily reshape the cornea, providing clear vision without the need for glasses or daytime contact lenses. [14] Possible mechanisms include improvement in peripheral retinal defocus and application of positive pressure to the central cornea.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study

Guo,

Liu,

et al. 2024

Medicine

View full text Add to dashboard Cite

It aims to study the efficacy and safety of low-concentration Atropine combined with orthokeratology (OK) lens in delaying juvenile myopia. This is a prospective study, 172 adolescents aged 8 to 12 years who were admitted to the diopter department of Hengshui People Hospital from April 2021 to May 2022 were selected. According to the equivalent spherical diopter measured at the time of initial diagnosis, myopic patients were randomly divided into low myopia group (group A) and moderate myopia group (group B). At the same time, according to the different treatment methods, the patients were divided into the group wearing frame glasses alone (group c), the group wearing frame glasses with low-concentration Atropine (group d), the group wearing corneal shaping glasses alone at night (group e), and the group wearing corneal shaping glasses at night with low-concentration Atropine (group f). The control effect of myopia development and axial elongation in group f was better than that in groups d and e (P < .05). The effect of controlling myopia development and axial elongation in group f is with P > .05. The probability of postoperative adverse reactions in group f was lower and lower than that in the other groups. Low-concentration atropine combined with OK lens could effectively delay the development of juvenile myopia, and had a high safety. Low-concentration of Atropine would not have a significant impact on the basic tear secretion and tear film stability. Nightwear of OK lens also had no significant impact, but it would significantly reduce the tear film rupture time in the first 3 months, and at the same time, the tear film rupture time would be the same after 6 months as before treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study

Guo,

Liu,

et al. 2024

Medicine

View full text Add to dashboard Cite

show abstract

“…The prevalence of myopia and high myopia (≤-6D) is increasing excessively worldwide [12]Myopia prevalence rates are higher in Asian cities like Hong Kong, Singapore, Asia, and Taiwan [13]This prevalence is linked to urbanization, lifestyle changes, and higher rates of literacy and education. Increased myopia can cause pathologies like retinal detachment, cataract glaucoma, staphyloma myopic, macular degeneration [10,21,26], and myopic choroidal neovascularization (CNV) and it is one of the causes of blindness in many Countries [10,20,21]. However, what is worrying is that young people are on the front lines.…”

Section: Introductionmentioning

confidence: 99%

“…As a consequence, the elongation of the Ocular axis remains stimulated. [1,4,8,12,23] There are several alternative compensation studies., pharmaceutical atropine, [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22], optics the lens of frames, contact lens orthokeratology, flexible multifocal [2,5,9,18,19,22,24,25].Behavioral given the increased prevalence of myopia worldwide, and the growing number of myopia. Patients that we receive daily in practice in our Moroccan optical.…”

Section: Introductionmentioning

confidence: 99%

The impact of visual environment on the evolution of myopia

Jelloul,

Boulezhar,

Afifi

et al. 2023

E3S Web Conf.

View full text Add to dashboard Cite

Our study represents the impact of the visual environment on the evolution of myopia. We established a statistical study of different types of myopia in Morocco. We classed with degrees of myopia. The long-term work of near vision increases a vision-postural stress leads to an increase in accommodative visual stress and convergence, and the correction with traditional lenses leads to hyperopic defocusing peripheral, which stimulates the elongation of the optical axis [1, 4]. We found that the number of myopia is changing during the four years of study and that the correction by traditional lenses does not allow us to slow down the evolution of myopia., this type of management and the visual environment leads us to an increase in the degrees and number of myopia during the four years. The increase in the power of myopia can lead to a pathological state that is preoccupant. We find that the visual environment has an impact on the increase of different types of myopia, especially average myopia in young people. So we have to try new alternatives for myopia compensation as special lenses for myopia braking and orthokeratology lens contact as well as behavioral and environmental measures to decrease visuals.

show abstract

Difference in the effect of orthokeratology on slowing teen myopia with different years of follow-up

Cited by 2 publications

References 17 publications

Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study

Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: An observational study

The impact of visual environment on the evolution of myopia

Contact Info

Product

Resources

About